Elite Pharmaceuticals Inc (ELTP)

[The ELTP King]

********** WTF!!!!!!!!!!!!!!!?????????? **********


Active Ingredient: DOXYCYCLINE HYCLATE
Approval Date: Mar 30, 2022
Applicant Holder Full Name: PRAXGEN PHARMACEUTICALS LLC
Marketing Status: Discontinued
Discontinued month: August 2022


https://www.accessdata.fda.gov/scripts/cder/ob/results_product.cfm?Appl_Type=A&Appl_No=212487#19670


Elite Pharmaceuticals And Praxgen Pharmaceuticals Receive FDA Approval For Generic Doxycycline

NORTHVALE, NJ / April 4, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that together with Elite's co-development partner, Praxgen Pharmaceuticals LLC, formerly SunGen Pharma LLC, ("Praxgen") received approval from the US Food and Drug Administration (FDA) for doxycycline hyclate 100 mg tablets. Doxycycline hyclate is an antibiotic that is used to treat a wide variety of bacterial infections.



-----------------------------------------------------------------------------------------------------------------------------------